Publications by authors named "Chandrin Jayatilleke"
Article Synopsis
- X-linked hypophosphataemia (XLH) is a chronic disorder that leads to bone deformities and affects quality of life due to symptoms like pain and fatigue.
- Burosumab, a treatment for XLH, was approved for adults in 2020 and has shown positive effects in patients.
- Three adults with ongoing XLH symptoms reported significant improvements in various aspects of their health, including pain relief, increased mobility, and better overall well-being after receiving burosumab treatment.
